Indacaterol Maleate Patent Expiration
Indacaterol Maleate is Used for managing airflow obstruction in patients with COPD. It was first introduced by Novartis Pharmaceuticals Corp
Indacaterol Maleate Patents
Given below is the list of patents protecting Indacaterol Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Arcapta Neohaler | US6878721 | Beta2-adrenoceptor agonists | Feb 25, 2025 | Novartis |
| Arcapta Neohaler | US8067437 | Beta-2-adrenoreceptor agonists |
Jun 02, 2020
(Expired) | Novartis |
| Arcapta Neohaler | US8479730 | Inhaler device | Oct 11, 2028 | Novartis |
| Arcapta Neohaler | US8658673 | BETA2-adrenoreceptor agonists |
Jun 02, 2020
(Expired) | Novartis |
| Arcapta Neohaler | US8796307 | Beta2-adrenoreceptor agonists |
Jun 02, 2020
(Expired) | Novartis |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳